IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

NCT06974812 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Unresectable Locally Advanced or Metastatic Solid Tumors

Interventions

DRUG: IBI3014
DRUG: IBI3014
DRUG: IBI3014
DRUG: IBI3014
DRUG: IBI3014
DRUG: IBI3014
DRUG: IBI3014
DRUG: IBI3014

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.